Guttmacher Institute. Contraceptive use in the United States by demographics. https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states
- Daniels K, Abma JC. NCHS Data Brief No 388. Current contraceptive status among women aged 15-49: United States, 2017-2019. NCHS Data Brief No 388. National Center for Health Statistics; 2020.
Petterson SM, Bazemore AW, Phillips RL, Rayburn WF. Trends in office-based care for reproductive-aged women according to physician specialty: a ten-year study. J Womens Health (Larchmt). 2014;23(12):1021-1026.
Solo J, Festin M. Provider bias in family planning services: a review of its meaning and manifestations. Glob Health Sci Pract. 2019;7(3):371-385.
SisterSong. Reproductive justice. https://www.sistersong.net/reproductive-justice
American College of Obstetricians and Gynecologists’ Committee on Health Care for Underserved Women, Contraceptive Equity Expert Work Group, and Committee on Ethics. Patient-centered contraceptive counseling: ACOG Committee Statement Number 1. Obstet Gynecol. 2022;139(2):350-353.
Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659-673.
Mittal P, Dandekar A, Hessler D. Use of a modified reproductive life plan to improve awareness of preconception health in women with chronic disease. Perm J. 2014;18(2):28-32.
Callegari LS, Aiken AR, Dehlendorf C, Cason P, Borrero S. Addressing potential pitfalls of reproductive life planning with patient-centered counseling. Am J Obstet Gynecol. 2017;216(2):129-134.
Dehlendorf C, Henderson JT, Vittinghoff E, Steinauer J, Hessler D. Development of a patient-reported measure of the interpersonal quality of family planning care. Contraception. 2018;97(1):34-40.
Gavin L, Moskosky S, Carter M. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep. 2014;63(RR-04):1-54.
Partners in Contraceptive Choice and Knowledge. Contraception guide, contraception information sheets, and postpartum contraception guide. https://picck.org/resource/contraception-guide-contraception-information-sheets-and-postpartum-contraception-guide/
Festin MPR. Overview of modern contraception. Best Pract Res Clin Obstet Gynaecol. 2020;66:4-14.
Coverage of certain preventive services under the Affordable Care Act. Fed Regist. 2015;80(134):41317-44147.
Health Resources & Services Administration. Women’s preventive services guidelines. https://www.hrsa.gov/womens-guidelines-2016
Judge-Golden CP, Smith KJ, Mor MK, Borrero S. Financial implications of 12-month dispensing of oral contraceptive pills in the Veterans Affairs health care system. JAMA Intern Med. 2019;179(9):1201-1208.
Society for Adolescent Health and Medicine; American Academy of Pediatrics. Confidentiality protections for adolescents and young adults in the health care billing and insurance claims process. J Adolesc Health. 2016;58(3):374-377.
Brittain AW, Loyola Briceno AC, Pazol K. Youth-friendly family planning services for young people: a systematic review update. Am J Prev Med. 2018;55(5):725-735.
- Nelson AL, Hardwood B. Vaginal barriers and spermicides. In: Hatcher RA, Nelson AL, Trussell J, eds. Contraceptive Technology. 21st ed. Ayer Company Publishers; 2018:367-394.
Partners in Contraceptive Choice and Knowledge (PICCK). Contraception (birth control) guide. https://picck.org/wp-content/uploads/2022/11/Contraception-Birth-Control-Guide-English.pdf
Steinberg J, Lynch SE. Lactic acid, citric acid, and potassium bitartrate (Phexxi) vaginal gel for contraception. Am Fam Physician. 2021;103(10):628-629.
Simmons RG, Jennings V. Fertility awareness-based methods of family planning. Best Pract Res Clin Obstet Gynaecol. 2020;66:68-82.
- World Health Organization. Natural Family Planning: A Guide to Provision of Services. WHO; 1988. https://iris.who.int/handle/10665/39322?locale-attribute=en&
Daniels K, Mosher WD. Contraceptive methods women have ever used: United States, 1982-2010. Natl Health Stat Rep. 2013;62:1-15.
- Jones RK. Coitus interruptus (withdrawal, pulling out). In: Hatcher RA, Nelson AL, Trussell J, eds. Contraceptive Technology. 21st ed. Ayer Company Publishers; 2018:451-458.
- Kennedy KI, Goldsmith C. Contraception after pregnancy. In: Hatcher RA, Nelson AL, Trussell J, eds. Contraceptive Technology. 21st ed. Ayer Company Publishers; 2018:511-542.
Guttmacher Institute. Contraceptive use in the United States by method. https://www.guttmacher.org/fact-sheet/contraceptive-method-use-united-states
Peterson HB, Hulka JF, Phillips JM, Surrey MW. Laparoscopic sterilization. American Association of Gynecologic Laparoscopists 1991 membership survey. J Reprod Med. 1993;38(8):574-576.
Jamieson DJ, Hillis SD, Duerr A, Marchbanks PA, Costello C, Peterson HB. Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol. 2000;96(6):997-1002.
Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. N Engl J Med. 1997;336(11):762-767.
Carmona F, Cristóbal P, Casamitjana R, Balasch J. Effect of tubal sterilization on ovarian follicular reserve and function. Am J Obstet Gynecol. 2003;189(2):447-452.
DeStefano F, Perlman JA, Peterson HB, Diamond EL. Long-term risk of menstrual disturbances after tubal sterilization. Am J Obstet Gynecol. 1985;152(7 Pt 1):835-841.
Costello C, Hillis SD, Marchbanks PA, Jamieson DJ, Peterson HB. The effect of interval tubal sterilization on sexual interest and pleasure. Obstet Gynecol. 2002;100(3):511-517.
Yunker AC, Ritch JM, Robinson EF, Golish CT. Incidence and risk factors for chronic pelvic pain after hysteroscopic sterilization. J Minim Invasive Gynecol. 2015;22(3):390-394.
Kavanaugh ML, Pliskin E. Use of contraception among reproductive-aged women in the United States, 2014 and 2016. F S Rep. 2020;1(2):83-93.
Ostrowski KA, Holt SK, Haynes B, Davies BJ, Fuchs EF, Walsh TJ. Evaluation of vasectomy trends in the United States. Urology. 2018;118:76-79.
Rayala BZ, Viera AJ. Common questions about vasectomy. Am Fam Physician. 2013;88(11):757-761.
Cook LA, Pun A, Gallo MF, Lopez LM, Van Vliet HA. Scalpel versus no-scalpel incision for vasectomy. Cochrane Database Syst Rev. 2014(3):CD004112.
Sharlip ID, Belker AM, Honig S. Vasectomy: AUA guideline. J Urol. 2012;188(6 Suppl):2482-2491.
Hofmeyr DG, Greeff AP. The influence of a vasectomy on the marital relationship and sexual satisfaction of the married man. J Sex Marital Ther. 2002;28(4):339-351.
- Code of Federal Regulations. Consent for sterilization. 42 CFR § 441.258. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-C/part-441/subpart-F/section-441.258
Blumenthal PD, Edelman A. Hormonal contraception. Obstet Gynecol. 2008;112(3):670-684.
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206-218.
Curtis KM, Jatlaoui TC, Tepper NK. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(4):1-66.
Curtis KM, Tepper NK, Jatlaoui TC. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(3):1-103.
Curtis KM, Zapata LB, Pagano HP, Nguyen A, Reeves J, Whiteman MK. Removing unnecessary medical barriers to contraception: celebrating a decade of the U.S. medical eligibility criteria for contraceptive use. J Womens Health (Larchmt). 2021;30(3):293-300.
Centers for Disease Control and Prevention; National Center for Health Statistics. National Survey of Family Growth. Key statistics. https://www.cdc.gov/nchs/nsfg/keystatistics.htm
Edelman A, Micks E, Gallo MF, Jensen JT, Grimes DA. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014(7):CD004695.
Stanczyk FZ. All progestins are not created equal. Steroids. 2003;68(10-13):879-890.
Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(1):76-105.
Chen MJ, Jensen JT, Kaunitz AM. Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: pooled analysis of two multicenter, open-label phase 3 trials. Contraception. 2022;116:44-50.
Baker CC, Chen MJ. New Contraception update—Annovera, Phexxi, Slynd, and Twirla. Curr Obstet Gynecol Rep. 2022;11(1):21-27.
van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception. 2005;72(3):168-174.
Food and Drug Administration. FDA approves first nonprescription daily oral contraceptive. https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive
- Chuck E. Now that an over-the-counter birth control pill is approved, here’s how, when and where you’ll be able to get it. NBC News. https://www.nbcnews.com/health/womens-health/opill-over-the-counter-birth-control-pill-when-where-to-get-rcna94151
Allen RH, Bartz D. Opill: the over-the-counter contraceptive pill. Obstet Gynecol. 2024;143(2):184-188.
- Long M, Diep K, Sobel L, Salganicoff A. Considerations for covering over-the-counter contraception. KFF Women’s Health Policy. 2023. https://www.kff.org/policy-watch/considerations-covering-over-the-counter-contraception/
Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B. Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide. Contraception. 2011;84(6):549-557.
Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol. 1994;170(5 Pt 2):1543-1549.
Clinical Key. Clinical Pharmacology. Medroxyprogesterone. https://www.clinicalkey.com/pharmacology/monograph/369?n=Medroxyprogesterone
Reproductive Health Access Project. Skipping periods on birth control. https://www.reproductiveaccess.org/wp-content/uploads/2014/12/skipping_periods.pdf
American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus—Gynecology. General approaches to medical management of menstrual suppression: ACOG Clinical Consensus No. 3. Obstet Gynecol. 2022;140(3):528-541.
- Etonogestrel-ethinyl estradiol vaginal ring. Package insert. Organon Pharmaceuticals; Jersey City, NJ; 2023. https://www.organon.com/product/usa/pi_circulars/n/nuvaring/nuvaring_pi.pdf
Curtis KM, Nguyen A, Reeves JA, Clark EA, Folger SG, Whiteman MK. Update to U.S. selected practice recommendations for contraceptive use: self-administration of subcutaneous depot medroxyprogesterone acetate. MMWR Morb Mortal Wkly Rep. 2021;70(20):739-743.
Reproductive Health Access Project. Depo-Provera Sub-Q user guide. https://www.reproductiveaccess.org/resource/depo-subq-user-guide/
Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014(1):CD003987.
Lopez LM, Ramesh S, Chen M. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016(8):CD008815.
de Bastos M, Stegeman BH, Rosendaal FR. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014(3):CD010813.
Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG committee opinion, No. 785. Obstet Gynecol. 2019;134(3):e71-e83.
Van Vliet HA, Grimes DA, Lopez LM, Schulz KF, Helmerhorst FM. Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev. 2011(11):CD003553.
Henderson JT, Sawaya GF, Blum M, Stratton L, Harper CC. Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol. 2010;116(6):1257-1264.
Qin J, Saraiya M, Martinez G, Sawaya GF. Prevalence of potentially unnecessary bimanual pelvic examinations and Papanicolaou tests among adolescent girls and young women aged 15-20 years in the United States. JAMA Intern Med. 2020;180(2):274-280.
Lesnewski R. Initiating hormonal contraception. Am Fam Physician. 2021;103(5):291-300.
Westhoff C, Kerns J, Morroni C, Cushman LF, Tiezzi L, Murphy PA. Quick start: novel oral contraceptive initiation method. Contraception. 2002;66(3):141-145.
Reproductive Health Access Project. Quick start algorithm. https://www.reproductiveaccess.org/resource/quick-start-algorithm/
Brahmi D, Curtis KM. When can a woman start combined hormonal contraceptives (CHCs)? A systematic review. Contraception. 2013;87(5):524-538.
Jensen JT, Kaunitz AM, Achilles SL. Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials. Contraception. 2022;116:37-43.
Norelgestromin and ethinyl estradiol transdermal system. Package insert. Mylan Pharmaceuticals Inc; 2022.
Nuako A, Tu L, Reyes KJC, Chhabria SM, Stanford FC. Pharmacologic treatment of obesity in reproductive aged women. Curr Obstet Gynecol Rep. 2023;12(2):138-146.
Health care for transgender and gender diverse individuals: ACOG Committee Opinion, Number 823. Obstet Gynecol. 2021;137(3):e75-e88.
Taub RL, Ellis SA, Neal-Perry G, Magaret AS, Prager SW, Micks EA. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol. 2020;223(2):229.e1-229.e8.
Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. Am J Obstet Gynecol. 2020;222(2):134-143.
Committee Opinion No. 602: Depot medroxyprogesterone acetate and bone effects. Obstet Gynecol. 2014;123(6):1398-1402.
Gomez AM, Fuentes L, Allina A. Women or LARC first? Reproductive autonomy and the promotion of long-acting reversible contraceptive methods. Perspect Sex Reprod Health. 2014;46(3):171-175.
Lohr PA, Lyus R, Prager S. Use of intrauterine devices in nulliparous women. Contraception. 2017;95(6):529-537.
Reproductive Health Access Project. IUD fact sheet. https://www.reproductiveaccess.org/resource/iud-facts/
Dethier D, Qasba N, Kaneshiro B. Society of Family Planning clinical recommendation: extended use of long-acting reversible contraception. Contraception. 2022;113:13-18.
Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril. 2014;101(6):1656-1662.e4.
Jonsson B, Landgren BM, Eneroth P. Effects of various IUDs on the composition of cervical mucus. Contraception. 1991;43(5):447-458.
Guttinger A, Critchley HO. Endometrial effects of intrauterine levonorgestrel. Contraception. 2007;75(6 Suppl):S93-S98.
Higgins JA. Celebration meets caution: LARC’s boons, potential busts, and the benefits of a reproductive justice approach. Contraception. 2014;89(4):237-241.
Bahamondes L, Valeria Bahamondes M, Shulman LP. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update. 2015;21(5):640-651.
Wu JP, Pickle S. Extended use of the intrauterine device: a literature review and recommendations for clinical practice. Contraception. 2014;89(6):495-503.
Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181(5 Pt 1):1263-1269.
Ali M, Akin A, Bahamondes L. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31(11):2491-2498.
Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol. 2007;50(4):907-917.
Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011;117(3):705-719.
- Burton S. What women endure. New York Times. July 30, 2023. https://www.nytimes.com/2023/07/30/briefing/the-retrievals-serial.html
Lopez LM, Bernholc A, Zeng Y. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2015(7):CD007373.
Nguyen L, Lamarche L, Lennox R. Strategies to mitigate anxiety and pain in intrauterine device insertion: a systematic review. J Obstet Gynaecol Can. 2020;42(9):1138-1146.e2.
- Cohen R, Teal SB. Implantable contraception. In: Jensen JT, Creinin MD, eds. Speroff & Darney’s Clinical Guide to Contraception. 6th ed. Wolters Kluwer; 2019:133-168.
Betstadt SJ, Turok DK, Kapp N, Feng KT, Borgatta L. Intrauterine device insertion after medical abortion. Contraception. 2011;83(6):517-521.
Reproductive Health Access Project. How to switch birth control methods. https://www.reproductiveaccess.org/wp-content/uploads/2014/12/switching_bc.pdf
Allen RH, Cwiak CA, Kaunitz AM. Contraception in women over 40 years of age. CMAJ. 2013;185(7):565-573.
Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception. 2013;87(5):655-660.
Foster DG, Grossman D, Turok DK. Interest in and experience with IUD self-removal. Contraception. 2014;90(1):54-59.
Reproductive Health Access Project. Contraceptive pearls: IUD self-removal. https://www.reproductiveaccess.org/resource/contraceptive-pearls-iud-self-removal/
Schultheis P, Montoya MN, Zhao Q, Archer J, Madden T, Peipert JF. Contraception and ectopic pregnancy risk: a prospective observational analysis. Am J Obstet Gynecol. 2021;224(2):228-229.
Caliskan E, Oztürk N, Dilbaz BO, Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care. 2003;8(3):150-155.
Heinemann K, Reed S, Moehner S, Minh TD. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception. 2015;91(4):274-279.
Rowlands S, Oloto E, Horwell DH. Intrauterine devices and risk of uterine perforation: current perspectives. Open Access J Contracept. 2016;7:19-32.
van Grootheest K, Sachs B, Harrison-Woolrych M, Caduff-Janosa P, van Puijenbroek E. Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres. Drug Saf. 2011;34(1):83-88.
Fassett MJ, Reed SD, Rothman KJ. Risks of uterine perforation and expulsion associated with intrauterine devices. Obstet Gynecol. 2023;142(3):641-651.
Christelle K, Norhayati MN, Jaafar SH. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2022(8):CD006034.
Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009;80(6):519-526.
Reinprayoon D, Taneepanichskul S, Bunyavejchevin S. Effects of the etonogestrel-releasing contraceptive implant (Implanon®) on parameters of breastfeeding compared to those of an intrauterine device. Contraception. 2000;62(5):239-246.
Anthony MS, Zhou X, Schoendorf J. Demographic, reproductive, and medical risk factors for intrauterine device expulsion. Obstet Gynecol. 2022;140(6):1017-1030.
Rocca ML, Palumbo AR, Visconti F, Di Carlo C. Safety and benefits of contraceptives implants: a systematic review. Pharmaceuticals (Basel). 2021;14(6):548.
Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004(350):1-36.
Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency contraception. Cochrane Database Syst Rev. 2019(1):CD001324.
Practice Bulletin No. 152: emergency contraception. Obstet Gynecol. 2015;126(3):e1-e11.
Turok DK, Gero A, Simmons RG. Levonorgestrel vs. copper intrauterine devices for emergency contraception. N Engl J Med. 2021;384(4):335-344.
Salcedo J, Cleland K, Bartz D, Thompson I. Society of Family Planning clinical recommendation: emergency contraception. Contraception. 2023;121:109958.
Jatlaoui TC, Curtis KM. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. Contraception. 2016;94(6):605-611.
Festin MPR, Peregoudov A, Seuc A, Kiarie J, Temmerman M. Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies. Contraception. 2017;95(1):50-54.
Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 2016;374(9):843-852.
Centers for Disease Control and Prevention. About teen pregnancy. https://www.cdc.gov/teenpregnancy/about/index.htm
Singer J. Options counseling: techniques for caring for women with unintended pregnancies. J Midwifery Womens Health. 2004;49(3):235-242.
Jones J. Adoption experiences of women and men and demand for children to adopt by women 18-44 years of age in the United States, 2002. Vital Health Stat 23. 2008(27):1-36.
Nelson HD, Darney BG, Ahrens K. Associations of unintended pregnancy with maternal and infant health outcomes: a systematic review and meta-analysis. JAMA. 2022;328(17):1714-1729.
Foster DG, Biggs MA, Ralph L, Gerdts C, Roberts S, Glymour MM. Socioeconomic outcomes of women who receive and women who are denied wanted abortions in the United States. Am J Public Health. 2018;108(3):407-413.
Roberts SC, Biggs MA, Chibber KS, Gould H, Rocca CH, Foster DG. Risk of violence from the man involved in the pregnancy after receiving or being denied an abortion. BMC Med. 2014;12:144.
Foster DG, Biggs MA, Raifman S, Gipson J, Kimport K, Rocca CH. Comparison of health, development, maternal bonding, and poverty among children born after denial of abortion vs after pregnancies subsequent to an abortion. JAMA Pediatr. 2018;172(11):1053-1060.
Foster DG, Raifman SE, Gipson JD, Rocca CH, Biggs MA. Effects of carrying an unwanted pregnancy to term on women’s existing children. J Pediatr. 2019;205:183-189.e1.
Holt K, Janiak E, McCormick MC. Pregnancy options counseling and abortion referrals among US primary care physicians: results from a national survey. Fam Med. 2017;49(7):527-536.
- Aiken AR, Borrero S, Callegari LS, Dehlendorf C. Rethinking the pregnancy planning paradigm: unintended conceptions or unrepresentative concepts? Perspect Sex Reprod Health. 2016;48(3):147-151.
American Academy of Family Physicians. Reproductive decisions, training in. https://www.aafp.org/about/policies/all/reproductive-decisions-training.html
- Accreditation Council for Graduate Medical Education (ACGME). ACGME program requirements for graduate medical education in family medicine. https://www.acgme.org/globalassets/pfassets/programrequirements/120_familymedicine_2022.pdf
Accreditation Council for Graduate Medical Education (ACGME). Program requirements, FAQs, and applications. https://www.acgme.org/specialties/family-medicine/program-requirements-and-faqs-and-applications/
Provide. Practice guide for all-options pregnancy counseling. https://providecare.org/practice-guide-all-options-pregnancy-counseling/
Nobel K, Ahrens K, Handler A, Holt K. Patient-reported experience with discussion of all options during pregnancy options counseling in the US South. Contraception. 2022;106:68-74.
World Health Organization, Human Reproduction Programme. Availability and accessibility of information. https://srhr.org/abortioncare/chapter-1/availability-and-accessibility-of-information/
AdoptMatch. Open adoption rules and the post adoption agreement. https://www.adoptmatch.com/open-adoption-rules-post-adoption-agreement-by-state
- Kortsmit K, Nguyen AT, Mandel MG. Abortion surveillance—United States, 2020. MMWR Surveill Summ. 2022;71(10):1-27.
- Jones RK, Nash E, Cross L, Philbin J, Kirstein M. Medication abortion now accounts for more than half of all US abortions. Guttmacher Institute. https://www.guttmacher.org/article/2022/02/medication-abortion-now-accounts-more-half-all-us-abortions
Upadhyay UD, Desai S, Zlidar V. Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015;125(1):175-183.
Zane S, Creanga AA, Berg CJ. Abortion-Related Mortality in the United States: 1998-2010. Obstet Gynecol. 2015;126(2):258-265.
- Abrams Z. The facts about abortion and mental health. American Psychological Association. https://www.apa.org/monitor/2022/09/news-facts-abortion-mental-health
- Dobbs v Jackson Women’s Health Organization, 597 U.S. 215 (2022). https://www.supremecourt.gov/opinions/21pdf/19-1392_6j37.pdf
Society for Maternal-Fetal Medicine. Clinical considerations for management of severe complications when abortion care is restricted. https://www.smfm.org/publications/450-clinical-considerations-for-management-of-severe-complications-when-abortion-care-is-restricted
Aiken ARA, Starling JE, Scott JG, Gomperts R. Association of Texas Senate Bill 8 with requests for self-managed medication abortion. JAMA Netw Open. 2022;5(2):e221122.
Moseson H, Herold S, Filippa S, Barr-Walker J, Baum SE, Gerdts C. Self-managed abortion: a systematic scoping review. Best Pract Res Clin Obstet Gynaecol. 2020;63:87-110.
Aiken ARA, Romanova EP, Morber JR, Gomperts R. Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: a population based study. Lancet Reg Health Am. 2022;10:100200.
- Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD, eds. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Blackwell Publishing Ltd; 2009.
Henshaw RC, Naji SA, Russell IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women’s preferences and acceptability of treatment. BMJ. 1993;307(6906):714-717.
- National Abortion Federation. Clinical Policy Guidelines for Abortion Care. National Abortion Federation; 2022. https://prochoice.org/wp-content/uploads/2022-CPGs.pdf
American College of Obstetricians and Gynecologists’ Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists’ Abortion Access and Training Expert Work Group. Increasing access to abortion: ACOG Committee Opinion, No. 815. Obstet Gynecol. 2020;136(6):e107-e115.
Montoya MN, Judge-Golden C, Swartz JJ. The problems with crisis pregnancy centers: reviewing the literature and identifying new directions for future research. Int J Womens Health. 2022;14:757-763.
Dobkin LM, Perrucci AC, Dehlendorf C. Pregnancy options counseling for adolescents: overcoming barriers to care and preserving preference. Curr Probl Pediatr Adolesc Health Care. 2013;43(4):96-102.
Kulier R, Kapp N. Comprehensive analysis of the use of pre-procedure ultrasound for first- and second-trimester abortion. Contraception. 2011;83(1):30-33.
Raymond EG, Bracken H. Early medical abortion without prior ultrasound. Contraception. 2015;92(3):212-214.
Kapp N, Whyte P, Tang J, Jackson E, Brahmi D. A review of evidence for safe abortion care. Contraception. 2013;88(3):350-363.
Horvath S, Tsao P, Huang ZY. The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization. Contraception. 2020;102(1):1-6.
- World Health Organization, Human Reproduction Programme. Recommendations and best practice statements across the continuum of abortion care, clinical services recommendation 8: Rh isoimmunization for abortion at gestational ages < 12 weeks. In: Abortion Care Guideline. World Health Organization; 2022. https://srhr.org/abortioncare/chapter-3/pre-abortion-3-3/clinical-services-recommendation-8-rh-isoimmunization-for-abortion-at-gestational-ages-12-weeks-3-3-3/
Raymond EG, Grossman D, Mark A. Commentary: no-test medication abortion: a sample protocol for increasing access during a pandemic and beyond. Contraception. 2020;101(6):361-366.
Macnaughton H, Nothnagle M, Early J. Mifepristone and misoprostol for early pregnancy loss and medication abortion. Am Fam Physician. 2021;103(8):473-480.
Raymond EG, Mark A, Grossman D. Medication abortion with misoprostol-only: a sample protocol. Contraception. 2023;121:109998-109998.
U.S. Food & Drug Administration. Drugs@FDA: FDA-approved drugs. New Drug Application (NDA) 020687. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020687
Danco Laboratories, LLC. Prescribing Mifeprex (mifepristone). https://www.earlyoptionpill.com/for-health-professionals/prescribing-mifeprex/
GenBioPro. Prescribing. https://genbiopro.com/prescribing/
Kohn JE, Snow JL, Simons HR, Seymour JW, Thompson TA, Grossman D. Medication abortion provided through telemedicine in four U.S. states. Obstet Gynecol. 2019;134(2):343-350.
Godfrey EM, Thayer EK, Fiastro AE, Aiken ARA, Gomperts R. Family medicine provision of online medication abortion in three US states during COVID-19. Contraception. 2021;104(1):54-60.
Fiastro AE, Sanan S, Jacob-Files E. Remote delivery in reproductive health care: operation of direct-to-patient telehealth medication abortion services in diverse settings. Ann Fam Med. 2022;20(4):336-342.
U.S. Food & Drug Administration. Information about mifepristone for medical termination of pregnancy through ten weeks gestation. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation
- Fleming M, Shih G, Goodman S, eds. TEACH Abortion Training Curriculum. 7th ed. UCSF Bixby Center for Global Reproductive Health; 2022.
- Mifepristone. Package insert. Danco Laboratories; New York; 2016.
Harris LH, Grossman D. Complications of unsafe and self-managed abortion. N Engl J Med. 2020;382(11):1029-1040.
Bennett IM, Baylson M, Kalkstein K, Gillespie G, Bellamy SL, Fleischman J. Early abortion in family medicine: clinical outcomes. Ann Fam Med. 2009;7(6):527-533.
White K, Carroll E, Grossman D. Complications from first-trimester aspiration abortion: a systematic review of the literature. Contraception. 2015;92(5):422-438.
Paul M, Nobel K, Goodman S, Lossy P, Moschella JE, Hammer H. Abortion training in three family medicine programs: resident and patient outcomes. Fam Med. 2007;39(3):184-189.
Guiahi M, Davis A. First-trimester abortion in women with medical conditions: release date October 2012 SFP guideline #20122. Contraception. 2012;86(6):622-630.
